ES2183816T3 - Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion. - Google Patents

Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion.

Info

Publication number
ES2183816T3
ES2183816T3 ES93919688T ES93919688T ES2183816T3 ES 2183816 T3 ES2183816 T3 ES 2183816T3 ES 93919688 T ES93919688 T ES 93919688T ES 93919688 T ES93919688 T ES 93919688T ES 2183816 T3 ES2183816 T3 ES 2183816T3
Authority
ES
Spain
Prior art keywords
injection
procedure
production
fabrics
altered tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93919688T
Other languages
English (en)
Spanish (es)
Inventor
Hideo Okazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Lequio Pharma Co Ltd
Original Assignee
Mitsubishi Pharma Corp
Lequio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp, Lequio Pharma Co Ltd filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ES2183816T3 publication Critical patent/ES2183816T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES93919688T 1992-09-18 1993-09-20 Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion. Expired - Lifetime ES2183816T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27513292 1992-09-18

Publications (1)

Publication Number Publication Date
ES2183816T3 true ES2183816T3 (es) 2003-04-01

Family

ID=17551146

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93919688T Expired - Lifetime ES2183816T3 (es) 1992-09-18 1993-09-20 Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion.

Country Status (7)

Country Link
EP (1) EP0617964B1 (en:Method)
AU (1) AU673005B2 (en:Method)
CA (1) CA2129959C (en:Method)
DE (1) DE69332219T2 (en:Method)
ES (1) ES2183816T3 (en:Method)
TW (1) TW274049B (en:Method)
WO (1) WO1994006443A1 (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750150A (en) * 1992-09-18 1998-05-12 Traditional Chinese Medicine Research Laboratory, Inc. Compositions for treating affected tissues, method for the preparation and usage thereof
KR100329256B1 (ko) * 1993-11-17 2002-11-04 미츠비시 파마 코포레이션 병변이상조직 치료용 조성물,그의 제조방법 및 용도
US5773419A (en) * 1995-03-03 1998-06-30 Falcon; Juan Method of treating cancer with tannic acid
IL134425A0 (en) * 1997-08-08 2001-04-30 Atajje Inc Composition and method of treating cancer with tannic acid and tannin complexes
ES2303832T3 (es) * 2000-06-06 2008-09-01 Lequio Pharma Co., Ltd. Kit de composicion medica para tratar tejido anormal lesionado.
US7252834B2 (en) 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
WO2011014563A1 (en) 2009-07-29 2011-02-03 Vatrix Medical, Inc. Tissue stabilization for heart failure
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
JP2014516695A (ja) 2011-05-18 2014-07-17 バトリックス・メディカル・インコーポレイテッド 血管安定化用被覆バルーン

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56139423A (en) * 1980-04-02 1981-10-30 Toyo Seiyaku Kasei Kk Hemostatic agent for dental oral use
US4626433A (en) * 1985-05-20 1986-12-02 Preparation Gold, Inc. Remedy for hemorrhoids
DE3816442A1 (de) * 1988-05-13 1989-11-23 Tomic Dobrivoje Mittel zur behandlung mykotischer, mikrobischer und anderer gewebsschaedigender und pathologischer manifestationen und gewebsdeformationen
JP3133095B2 (ja) * 1990-04-25 2001-02-05 兆岐 史 消化器病変組織の硬化剤
AU653359B2 (en) * 1991-04-19 1994-09-29 Lequio Pharma Co. Ltd Hardening agent for affected tissues of the digestive system

Also Published As

Publication number Publication date
AU673005B2 (en) 1996-10-24
CA2129959A1 (en) 1994-03-03
DE69332219D1 (de) 2002-09-26
DE69332219T2 (de) 2003-01-09
TW274049B (en:Method) 1996-04-11
EP0617964A1 (en) 1994-10-05
EP0617964B1 (en) 2002-08-21
AU4984493A (en) 1994-04-12
CA2129959C (en) 2004-09-14
EP0617964A4 (en) 1999-12-29
WO1994006443A1 (fr) 1994-03-31

Similar Documents

Publication Publication Date Title
ES8802494A1 (es) Procedimiento para la obtencion de derivados de acidos benzoheterociclilalcanoicos
FI875308A0 (fi) Foerfarande i tvao steg foer att hela ett saor smaertfritt och ett vattenhaltigt medium och en salva foer lokal anvaendning vid foerfarandet.
ES2177579T3 (es) Solucion acuosa de factor viii de bajo contenido en oxigeno.
ES2093445T3 (es) Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos.
ES2060883T3 (es) Procedimiento de obtencion del acido carnosico.
ES8101540A1 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos.
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
NO883127L (no) Heling av saar og regenerering av ben.
ES416597A1 (es) Procedimiento de preparacion de albumina purificada.
ES2183816T3 (es) Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion.
SE8701662L (sv) Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna
MX9100230A (es) Solucion de celulosa en agua y n-metilmorfolina-n-oxido
ES2117426T3 (es) Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
SV1994000076A (es) Derivados de acido n-acetil neuraminico cristalino y su preparacion ref. 1123a/sv
EP0285278A3 (en) Method of treating anxiety with tetrahydrobenzûc,d¨indole-6-carboxamides
ATE27269T1 (de) Strahlenschutzmittel mit aminothioalkyl-struktur und verfahren zu ihrer herstellung.
NO933114D0 (no) Fremstilling av faktor ix
JPS567716A (en) Preventive and remedy for cerebral angiospasm
ATE59554T1 (de) Auf mercaptoethansulfonsaeuren basierende pharmazeutische zusammensetzungen, organische abkoemmlinge von mercaptoethansulfonsaeuren sowie verfahren zu deren herstellung.
ES2163528T3 (es) Una solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.
ES2048263T3 (es) Composicion liofilizada de mdm y metodo para su fabricacion.
DE3467340D1 (en) Process for purification of 1,2-unsaturated carboxylic acids and/or esters thereof
DE3476520D1 (en) Use of a mixture of compounds for the manufacture of a composition for the treatment of buerger's disease
RU93019277A (ru) Раствор для защиты и лечения заболеваний и повреждения роговицы "визитон"
ES551363A0 (es) Procedimiento para fabricar carbonato de sodio anhidro denso